Overview Travoprost 3-Month Safety and Efficacy Study Status: Completed Trial end date: 2012-08-01 Target enrollment: Participant gender: Summary The purpose of this study was to demonstrate that the intraocular pressure-lowering efficacy of Travoprost 0.003% is equivalent to TRAVATAN® in adult patients with open-angle glaucoma or ocular hypertension. Phase: Phase 3 Details Lead Sponsor: Alcon ResearchTreatments: Ophthalmic SolutionsPharmaceutical SolutionsTravoprost